AOC3 and cancer: The adjusted hazard ratios per one standard deviation increase in serum VAP-1 concentrations were 1.28 for cancer incidence (95% CI=1.01–1.62), 1.60 for cancer mortality (95% CI=1.14–2.23), and 1.38 for all-cause mortality (95% CI=1.09–1.75).